Eleni Venetsanakos

Eleni Venetsanakos is a seasoned professional in translational sciences, currently serving as Vice President at Day One Biopharmaceuticals since October 2019, where responsibilities include overseeing scientific development initiatives. Prior experience includes roles as Senior Director of Translational Sciences at the same company, Director of Pharmacology at IDEAYA Biosciences, and Director of Biology at Principia Biopharma, where Eleni led translational efforts for FGFRi, PRN1371. Additionally, Eleni held prominent positions at Novartis, Chiron Corporation, and UCSF, contributing significantly to various drug discovery and development projects across several therapeutic areas. Eleni holds a Bachelor of Science (Honours) in Biochemistry and Immunology from the University of Tasmania and a PhD in Tumour Immunology from Flinders University.